ophthalmology companies

Companies whose enriched business profile is tagged “ophthalmology”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• TARSUS PHARMACEUTICALS INC (TARS) Health Care — Tarsus Pharmaceuticals is an ophthalmology-focused biopharmaceutical company best known for XDEMVY, a treatment for Demodex blepharitis. ask →
• ANI PHARMACEUTICALS INC (ANIP) Health Care — ANI Pharmaceuticals is a specialized biopharma company focused on acquiring, developing, and marketing both branded and generic prescription drugs. ask →
• OCULAR THERAPEUTIX INC (OCUL) Health Care — Ocular Therapeutix develops sustained-release, bioresorbable hydrogel-based ocular therapies to address chronic and acute eye diseases. ask →
• OMEROS CORP (OMER) Health Care — A biopharmaceutical company bridging commercial success from its ocular surgery product with a clinical-stage pipeline targeting complement-mediated disorders. ask →
• STAAR SURGICAL (STAA) Health Care — STAAR Surgical is a medical device company focused on vision correction through its proprietary implantable lens technology. ask →
• HARROW INC (HROW) Health Care — Harrow is a commercial-stage ophthalmic pharmaceutical company dedicated to providing innovative eye care medications and solutions. ask →
• SPYGLASS PHARMA INC SHS (SGP) Health Care — Spyglass Pharma is developing a novel, integrated drug-delivery system to improve the administration of therapeutic medication during cataract surgery. ask →
• OPUS GENETICS INC (IRD) Health Care — Opus Genetics is a clinical-stage gene therapy company developing a portfolio of durable, one-time treatments for rare inherited retinal diseases. ask →
• SURROZEN INC (SRZN) Health Care — A clinical-stage biotechnology company leveraging its proprietary Wnt pathway modulation platform to develop innovative, tissue-selective therapeutics for serious ophthalmic diseases. ask →
• OCUGEN INC (OCGN) Health Care — Ocugen is a clinical-stage biotechnology company developing gene-agnostic modifier gene therapies to address significant unmet medical needs in blindness and retinal diseases. ask →
• ABEONA THERAPEUTICS INC (ABEO) Health Care — Abeona Therapeutics is a commercial-stage biopharmaceutical firm providing the first autologous cell-based gene therapy for the treatment of rare, debilitating RDEB skin wounds. ask →
• EYEPOINT INC (EYPT) Health Care — EyePoint Pharmaceuticals is a clinical-stage biotech developing long-acting, sustained-release ocular drug delivery technology to treat chronic retinal diseases. ask →
• BIOAGE LABS INC (BIOA) Health Care — A clinical-stage biotechnology company leveraging proprietary human aging datasets to develop therapies for metabolic and inflammation-driven diseases. ask →
• LINEAGE CELL THERAPEUTICS INC (LCTX) Health Care — Lineage Cell Therapeutics is a clinical-stage biotech developing off-the-shelf, allogeneic cell therapies for degenerative diseases of the eye, spinal cord, and auditory system. ask →
• LIFECORE BIOMEDICAL INC (LFCR) Health Care — Lifecore Biomedical is a specialized CDMO focused on the complex aseptic filling and manufacturing of sterile injectable drug products and bulk hyaluronic acid. ask →
• ENTRADA THERAPEUTICS INC (TRDA) Health Care — Entrada Therapeutics is developing a new class of intracellular genetic medicines using its proprietary endosomal escape vehicle technology to treat serious neuromuscular and retinal diseases. ask →
• LENZ THERAPEUTICS INC (LENZ) Health Care — LENZ Therapeutics is a commercial-stage ophthalmology company marketing VIZZ, a first-of-its-kind, once-daily aceclidine-based eye drop for treating presbyopia. ask →
• Aldeyra Therapeutics, Inc. (ALDX) Health Care — Biotechnology company developing novel RASP-modulating therapies to treat immune-mediated inflammatory diseases, with a lead focus on ocular health. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-10-20.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.